Prevalence and predictors of suicidality and non-suicidal self-harm among individuals at clinical high-risk for psychosis: Results from a community-recruited sample.
clinical high-risk
first-episode psychosis
psychosis
self-harm
suicidality
Journal
Early intervention in psychiatry
ISSN: 1751-7893
Titre abrégé: Early Interv Psychiatry
Pays: Australia
ID NLM: 101320027
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
revised:
03
09
2020
received:
08
07
2020
accepted:
15
11
2020
pubmed:
30
12
2020
medline:
29
10
2021
entrez:
29
12
2020
Statut:
ppublish
Résumé
Suicidal thoughts and behaviours are prevalent in individuals with schizophrenia. However, research examining the prevalence and predictors of suicidality and self-harm in participants at clinical high-risk for psychosis (CHR-P) is limited and mostly focuses on help-seeking participants recruited through clinical pathways. The current study sought to assess the prevalence of suicidality and self-harm and identify predictors of current suicidal ideation in community-recruited CHR-P participants. Data were available for 130 CHR-P participants, 15 participants with first-episode psychosis (FEP), 47 participants not fulfilling CHR-P criteria (CHR-Ns) and 53 healthy controls. Current and lifetime suicidality and self-harm were assessed using the Mini-International Neuropsychiatric Interview and the Comprehensive Assessment of At-Risk Mental States (CAARMS). Multivariable logistic regression analysis was used to determine predictors of current suicidal ideation in the CHR-P group. A considerable proportion of CHR-P participants disclosed current suicidal ideation (34.6%). Overall, FEP individuals were at greatest risk, with considerably high prevalence rates for current suicidal ideation (73.3%), lifetime self-harm behaviour (60.0%) and lifetime suicide attempt (60.0%). In the CHR-P sample, current suicidal ideation was predicted by lifetime suicide attempts, lower CAARMS severity, impaired social functioning and greater comorbidity. Our findings suggest that suicidality and self-harm are highly prevalent in community-recruited CHR-P and FEP individuals. Accordingly, these results highlight the importance of further research into the determinants of suicidality and self-harm during at-risk and early stages of psychosis, and the implementation of intervention strategies to reduce adverse outcomes in these populations.
Identifiants
pubmed: 33372364
doi: 10.1111/eip.13075
pmc: PMC8451831
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1256-1265Subventions
Organisme : Medical Research Council
ID : MR/N003403/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L011689/1
Pays : United Kingdom
Informations de copyright
© 2020 The Authors. Early Intervention in Psychiatry Published by John Wiley & Sons Australia, Ltd.
Références
J Affect Disord. 2013 Sep 5;150(2):540-5
pubmed: 23466401
BMJ. 2004 Jul 31;329(7460):261
pubmed: 15213108
Schizophr Res. 2009 Sep;113(2-3):145-50
pubmed: 19570653
Schizophr Bull. 1982;8(3):470-84
pubmed: 7134891
Schizophr Bull. 2019 Apr 25;45(3):600-609
pubmed: 29889271
Suicide Life Threat Behav. 2019 Dec;49(6):1637-1652
pubmed: 30932235
Early Interv Psychiatry. 2019 Jun;13(3):539-545
pubmed: 29164799
Crisis. 2015 Jun;36(2):79-82
pubmed: 30249123
Schizophr Bull. 2009 Jan;35(1):5-8
pubmed: 19074497
Psychol Med. 2015 Apr;45(5):911-26
pubmed: 25298008
Acta Psychiatr Scand. 2013 Jun;127(6):442-54
pubmed: 23298325
Schizophr Res. 2020 Jun;220:98-105
pubmed: 32249122
Br J Psychiatry Suppl. 2007 Dec;51:s140-6
pubmed: 18055932
Schizophr Bull. 2007 May;33(3):688-702
pubmed: 17440198
Psychol Rev. 2010 Apr;117(2):575-600
pubmed: 20438238
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
Psychiatry Investig. 2010 Jun;7(2):79-85
pubmed: 20577615
BMJ Open. 2016 Sep 27;6(9):e011929
pubmed: 27678536
J Psychiatr Pract. 2018 May;24(3):169-178
pubmed: 30015787
Am J Epidemiol. 2007 Mar 15;165(6):710-8
pubmed: 17182981
JAMA Psychiatry. 2013 Nov;70(11):1133-42
pubmed: 24006090
Arch Suicide Res. 2021 Jan-Mar;25(1):38-73
pubmed: 31545148
Schizophr Res. 2004 Jun 1;68(2-3):283-97
pubmed: 15099610
Mol Psychiatry. 2020 Jan;25(1):168-179
pubmed: 31570777
Schizophr Res Treatment. 2016;2016:3165243
pubmed: 26977319
Schizophr Res. 2012 Sep;140(1-3):110-3
pubmed: 22846651
Schizophr Res. 2016 Oct;176(2-3):364-370
pubmed: 27450776
Eur Arch Psychiatry Clin Neurosci. 2018 Feb;268(1):39-48
pubmed: 28054132
J Affect Disord. 2016 Mar 15;193:318-30
pubmed: 26774520
J Abnorm Psychol. 2017 Aug;126(6):726-738
pubmed: 28481571
PLoS One. 2017 Mar 16;12(3):e0173958
pubmed: 28301590
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
J Psychiatr Res. 2018 Jul;102:216-222
pubmed: 29698922
Early Interv Psychiatry. 2021 Oct;15(5):1256-1265
pubmed: 33372364
Compr Psychiatry. 2011 Sep-Oct;52(5):479-85
pubmed: 21185016
Curr Pharm Des. 2012;18(4):351-7
pubmed: 22239566
Psychol Med. 2013 Jan;43(1):49-60
pubmed: 22617391
J Clin Child Adolesc Psychol. 2015;44(5):751-61
pubmed: 24871489
Schizophr Res. 2015 Jul;165(2-3):152-6
pubmed: 25960038
Arch Gen Psychiatry. 2005 Mar;62(3):247-53
pubmed: 15753237
Schizophr Bull. 2012 Nov;38(6):1288-96
pubmed: 22516147
Aust N Z J Psychiatry. 2005 Nov-Dec;39(11-12):964-71
pubmed: 16343296
Schizophr Bull. 2016 May;42(3):732-43
pubmed: 26591006
J Affect Disord. 2019 Dec 1;259:302-313
pubmed: 31450139
BMC Psychiatry. 2017 Jan 26;17(1):43
pubmed: 28125984
JAMA Psychiatry. 2016 Feb;73(2):113-20
pubmed: 26719911
PLoS One. 2014 Oct 27;9(10):e109958
pubmed: 25347404
Am J Prev Med. 1998 May;14(4):245-58
pubmed: 9635069
Br J Clin Psychol. 1988 Nov;27(4):349-58
pubmed: 3214688